食管胃结合部腺癌外科治疗进展_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 季加孚 , 季科

北京大学肿瘤医院胃肠肿瘤中心（北京 100142）;

Corresponding author：

季加孚, Email: jijiafu@hsc.pku.edu.cn

Keywords：

DOI：

10.7507/1007-9424.201906113

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 季加孚, 季科. 食管胃结合部腺癌外科治疗进展. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2019, 26(9): 1021-1024. doi: 10.7507/1007-9424.201906113 Copy

1.	DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol, 2006, 13(1): 12-30.
2.	Lagergren J, Bergström R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med, 1999, 340(11): 825-831.
3.	Kauppila JH, Lagergren J. The surgical management of esophago-gastric junctional cancer. Surg Oncol, 2016, 25(4): 394-400.
4.	Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol, 2001, 30(6): 1415-1425.
5.	Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol, 2007, 17(1): 2-9.
6.	Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA, 1991, 265(10): 1287-1289.
7.	Siewert JR, Hölscher AH, Becker K, et al. Cardia cancer: attempt at a therapeutically relevant classification. Chirurg, 1987, 58(1): 25-32.
8.	Misumi A, Murakami A, Harada K, et al. Definition of carcinoma of the gastric cardia. Langenbecks Arch Chir, 1989, 374(4): 221-226.
9.	Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer, 2011, 14(2): 101-112.
10.	Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part Ⅱ and Ⅲ. Esophagus, 2017, 14(1): 37-65.
11.	Hasegawa S, Yoshikawa T, Aoyama T, et al. Esophagus or stomach? The seventh TNM classification for Siewert type Ⅱ/Ⅲ junctional adenocarcinoma. Ann Surg Oncol, 2013, 20(3): 773-779.
12.	Gertler R, Stein HJ, Loos M, et al. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer? Am J Surg Pathol, 2011, 35(10): 1512-1522.
13.	中华医学会消化内镜学分会, 中国抗癌协会肿瘤内镜学专业委员会. 中国早期胃癌筛查及内镜诊治共识意见(2014 年4月·长沙). 胃肠病学, 2014, 19(7): 408-427.
14.	Chevallay M, Bollschweiler E, Chandramohan SM, et al. Cancer of the gastroesophageal junction: a diagnosis, classification, and management review. Ann N Y Acad Sci, 2018, 1434(1): 132-138.
15.	国际食管疾病学会中国分会(CSDE)食管胃结合部疾病跨界联盟, 中国医师协会内镜医师分会腹腔镜外科专业委员会, 中国医师协会外科医师分会上消化道外科医师专业委员会, 等. 食管胃结合部腺癌外科治疗中国专家共识(2018年版). 中华胃肠外科杂志, 2018, 21(9): 961-975.
16.	Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg, 2007, 246(6): 992-1000.
17.	Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol, 2006, 7(8): 644-651.
18.	Kurokawa Y, Sasako M, Sano T, et al. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg, 2015, 102(4): 341-348.
19.	Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1 602 consecutive resected patients. Surg Oncol Clin N Am, 2006, 15(4): 751-764.
20.	Pedrazzani C, de Manzoni G, Marrelli D, et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg, 2007, 134(2): 378-385.
21.	Kitagawa Y. Total gastrectomy vs transthoracis escophagectomy: when and why? — The pattern of lymph node metastases in esophagogastric junction cancer: a nationawide prospective study in Japan. 13^th International Gastric Cancer Congress IGCC 2019, SS01-Multidisciplinary treatment of EG junction cancer, 2019, Abstract: IGCC-0933.
22.	Peracchia A, Bardini R, Bonavina L, et al. Adenocarcinoma of the cardia: the choice of surgical treatment. Ital J Surg Sci, 1987, 17(2): 123-129.
23.	Papachristou DN, Agnanti N, D’Agostino H, et al. Histologically positive esophageal margin in the surgical treatment of gastric cancer. Am J Surg, 1980, 139(5): 711-713.
24.	刘英俊, 韩广森, 王刚成, 等. 近端胃切除与全胃切除对Siewert Ⅱ~Ⅲ型食管胃结合部癌疗效比较的Meta分析. 中华胃肠外科杂志, 2014, 17(4): 373-377.
25.	Takiguchi N, Takahashi M, Ikeda M, et al. Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study. Gastric Cancer, 2015, 18(2): 407-416.
26.	日本胃癌学会編. 胃癌取扱い規約. 14版. 东京: 金原出版, 2010.
27.	Muraoka A, Kobayashi M, Kokudo Y. Laparoscopy-assisted proximal gastrectomy with the hinged double flap method. World J Surg, 2016, 40(10): 2419-2424.

1. DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol, 2006, 13(1): 12-30.
2. Lagergren J, Bergström R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med, 1999, 340(11): 825-831.
3. Kauppila JH, Lagergren J. The surgical management of esophago-gastric junctional cancer. Surg Oncol, 2016, 25(4): 394-400.
4. Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol, 2001, 30(6): 1415-1425.
5. Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol, 2007, 17(1): 2-9.
6. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA, 1991, 265(10): 1287-1289.
7. Siewert JR, Hölscher AH, Becker K, et al. Cardia cancer: attempt at a therapeutically relevant classification. Chirurg, 1987, 58(1): 25-32.
8. Misumi A, Murakami A, Harada K, et al. Definition of carcinoma of the gastric cardia. Langenbecks Arch Chir, 1989, 374(4): 221-226.
9. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer, 2011, 14(2): 101-112.
10. Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part Ⅱ and Ⅲ. Esophagus, 2017, 14(1): 37-65.
11. Hasegawa S, Yoshikawa T, Aoyama T, et al. Esophagus or stomach? The seventh TNM classification for Siewert type Ⅱ/Ⅲ junctional adenocarcinoma. Ann Surg Oncol, 2013, 20(3): 773-779.
12. Gertler R, Stein HJ, Loos M, et al. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer? Am J Surg Pathol, 2011, 35(10): 1512-1522.
13. 中华医学会消化内镜学分会, 中国抗癌协会肿瘤内镜学专业委员会. 中国早期胃癌筛查及内镜诊治共识意见(2014 年4月·长沙). 胃肠病学, 2014, 19(7): 408-427.
14. Chevallay M, Bollschweiler E, Chandramohan SM, et al. Cancer of the gastroesophageal junction: a diagnosis, classification, and management review. Ann N Y Acad Sci, 2018, 1434(1): 132-138.
15. 国际食管疾病学会中国分会(CSDE)食管胃结合部疾病跨界联盟, 中国医师协会内镜医师分会腹腔镜外科专业委员会, 中国医师协会外科医师分会上消化道外科医师专业委员会, 等. 食管胃结合部腺癌外科治疗中国专家共识(2018年版). 中华胃肠外科杂志, 2018, 21(9): 961-975.
16. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg, 2007, 246(6): 992-1000.
17. Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol, 2006, 7(8): 644-651.
18. Kurokawa Y, Sasako M, Sano T, et al. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg, 2015, 102(4): 341-348.
19. Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1 602 consecutive resected patients. Surg Oncol Clin N Am, 2006, 15(4): 751-764.
20. Pedrazzani C, de Manzoni G, Marrelli D, et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg, 2007, 134(2): 378-385.
21. Kitagawa Y. Total gastrectomy vs transthoracis escophagectomy: when and why? — The pattern of lymph node metastases in esophagogastric junction cancer: a nationawide prospective study in Japan. 13^th International Gastric Cancer Congress IGCC 2019, SS01-Multidisciplinary treatment of EG junction cancer, 2019, Abstract: IGCC-0933.
22. Peracchia A, Bardini R, Bonavina L, et al. Adenocarcinoma of the cardia: the choice of surgical treatment. Ital J Surg Sci, 1987, 17(2): 123-129.
23. Papachristou DN, Agnanti N, D’Agostino H, et al. Histologically positive esophageal margin in the surgical treatment of gastric cancer. Am J Surg, 1980, 139(5): 711-713.
24. 刘英俊, 韩广森, 王刚成, 等. 近端胃切除与全胃切除对Siewert Ⅱ~Ⅲ型食管胃结合部癌疗效比较的Meta分析. 中华胃肠外科杂志, 2014, 17(4): 373-377.
25. Takiguchi N, Takahashi M, Ikeda M, et al. Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study. Gastric Cancer, 2015, 18(2): 407-416.
26. 日本胃癌学会編. 胃癌取扱い規約. 14版. 东京: 金原出版, 2010.
27. Muraoka A, Kobayashi M, Kokudo Y. Laparoscopy-assisted proximal gastrectomy with the hinged double flap method. World J Surg, 2016, 40(10): 2419-2424.

Next Article
新辅助治疗在食管胃结合部腺癌中的应用

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

食管胃结合部腺癌外科治疗进展

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content